Literature DB >> 1629333

Human immunodeficiency virus type 1 is present in the cerebrospinal fluid of a majority of infected individuals.

F Chiodi1, B Keys, J Albert, L Hagberg, J Lundeberg, M Uhlén, E M Fenyö, G Norkrans.   

Abstract

Cerebrospinal fluid (CSF) specimens from 63 patients with different severities of human immunodeficiency virus (HIV-1) infection, including asymptomatic virus carriers, were examined for the presence of HIV-1 by using polymerase chain reaction (PCR) and virus isolation. Polyadenylated RNA, presumably associated with virus particles, was extracted and reverse transcribed, and the pol region was amplified in a nested PCR. Virus could be detected in 90% of the CSF specimens examined by PCR, and data on isolation of virus from CSF were in agreement with these figures. In fact, when several CSF specimens from the same individual were studied, HIV-1 could be isolated from 80% of the patients. The presence of the viral RNA in CSF was independent of the clinical stage of infection and of neurological symptoms. These results show that the spread of HIV-1 to the brain represents an early event during infection and occurs in the majority of asymptomatic individuals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629333      PMCID: PMC265378          DOI: 10.1128/jcm.30.7.1768-1771.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Replicative capacity of human immunodeficiency virus from patients with varying severity of HIV infection.

Authors:  B Asjö; L Morfeldt-Månson; J Albert; G Biberfeld; A Karlsson; K Lidman; E M Fenyö
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

2.  The AIDS dementia complex: I. Clinical features.

Authors:  B A Navia; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-06       Impact factor: 10.422

3.  Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection.

Authors:  F Chiodi; J Albert; E Olausson; G Norkrans; L Hagberg; A Sönnerborg; B Asjö; E M Fenyö
Journal:  AIDS Res Hum Retroviruses       Date:  1988-10       Impact factor: 2.205

4.  HTLV-III infection in brains of children and adults with AIDS encephalopathy.

Authors:  G M Shaw; M E Harper; B H Hahn; L G Epstein; D C Gajdusek; R W Price; B A Navia; C K Petito; C J O'Hara; J E Groopman
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

5.  Simple, sensitive, and specific detection of human immunodeficiency virus type 1 in clinical specimens by polymerase chain reaction with nested primers.

Authors:  J Albert; E M Fenyö
Journal:  J Clin Microbiol       Date:  1990-07       Impact factor: 5.948

6.  Amplification of HIV-1 provirus from cerebrospinal fluid and its correlation with neurologic disease.

Authors:  S Shaunak; R E Albright; M E Klotman; S C Henry; J A Bartlett; J D Hamilton
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

Review 7.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.

Authors:  R W Price; B Brew; J Sidtis; M Rosenblum; A C Scheck; P Cleary
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

8.  Human immunodeficiency virus infection of the brain. II. Detection of intrathecally synthesized antibodies by enzyme linked immunosorbent assay and imprint immunofixation.

Authors:  F Chiodi; G Norkrans; L Hagberg; A Sönnerborg; H Gaines; S Frøland; E M Fenyö; E Norrby; B Vandvik
Journal:  J Neurol Sci       Date:  1988-10       Impact factor: 3.181

9.  Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome.

Authors:  D D Ho; T R Rota; R T Schooley; J C Kaplan; J D Allan; J E Groopman; L Resnick; D Felsenstein; C A Andrews; M S Hirsch
Journal:  N Engl J Med       Date:  1985-12-12       Impact factor: 91.245

10.  Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: an evaluation of cytokines in cerebrospinal fluid.

Authors:  P Gallo; K Frei; C Rordorf; J Lazdins; B Tavolato; A Fontana
Journal:  J Neuroimmunol       Date:  1989-07       Impact factor: 3.478

View more
  14 in total

1.  HIV-1 replication in the plasma and cerebrospinal fluid.

Authors:  A Lafeuillade; C Poggi; P Pellegrino; K Corti; N Profizi; C Sayada
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

Review 2.  Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy.

Authors:  Francesca Ferretti; Magnus Gisslen; Paola Cinque; Richard W Price
Journal:  Curr HIV/AIDS Rep       Date:  2015-06       Impact factor: 5.071

3.  Molecular evidence and clinical significance of herpesvirus coinfection in the central nervous system.

Authors:  Y W Tang; M J Espy; D H Persing; T F Smith
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

Review 4.  Insights into the role of immune activation in HIV neuropathogenesis.

Authors:  Suzanne Gartner; Yiling Liu
Journal:  J Neurovirol       Date:  2002-04       Impact factor: 2.643

5.  Cerebrospinal fluid HIV viral load in different phases of HIV-associated brain disease.

Authors:  Hans-Jürgen von Giesen; Ortwin Adams; Hubertus Köller; Gabriele Arendt
Journal:  J Neurol       Date:  2005-03-06       Impact factor: 4.849

6.  Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera.

Authors:  J Albert; J Wahlberg; J Lundeberg; S Cox; E Sandström; B Wahren; M Uhlén
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

7.  Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with the RNA and DNA sequences of the virus populations of their mothers.

Authors:  G Scarlatti; T Leitner; E Halapi; J Wahlberg; P Marchisio; M A Clerici-Schoeller; H Wigzell; E M Fenyö; J Albert; M Uhlén
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  Intrathecal viral replication and cerebral deficits in different stages of human immunodeficiency virus disease.

Authors:  Gabriele Arendt; Thorsten Nolting; Christian Frisch; Ingo-Wilhelm Husstedt; Nora Gregor; Eleni Koutsilieri; Mattias Maschke; Alexander Angerer; Mark Obermann; Eva Neuen-Jacob; Ortwin Adams; Sabine Loeffert; Peter Riederer; Volker ter Meulen; Sieghart Sopper
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

9.  Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment.

Authors:  M Di Stefano; F Sabri; T Leitner; B Svennerholm; L Hagberg; G Norkrans; F Chiodi
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

Review 10.  Dimethyl fumarate modulation of immune and antioxidant responses: application to HIV therapy.

Authors:  Alexander J Gill; Dennis L Kolson
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.